Accès à distance ? S'identifier sur le proxy UCLouvain
The multiple pathways of endocannabinoid metabolism: a zoom out.
Primary tabs
Document type | Article de périodique (Journal article) – Journal Article, Research Support, Non-U.S. Gov't |
---|---|
Access type | Accès restreint |
Publication date | 2007 |
Journal information | "Chemistry & biodiversity" - Vol. 4, no. 8, p. 1858-81 (2007) |
Peer reviewed | yes |
issn | 1612-1872 |
e-issn | 1612-1880 |
Publication status | Publié |
Affiliation | UCL - MD/FARM - Ecole de pharmacie |
MESH Subject | Animals ; Endocannabinoids - metabolism ; Humans ; Hydrolases - chemistry - classification - metabolism ; Molecular Structure ; Oxygenases - chemistry - metabolism ; Signal Transduction |
Links |
- Devane, Science, 258, 1946 (1992)
- Pertwee, Prog. Neurobiol., 63, 569 (2001)
- Rice, Prostaglandins Leukot. Essent. Fatty Acids, 66, 243 (2002)
- Guindon, Eur. J. Pharmacol., 550, 68 (2006)
- Akerman, J. Pharmacol. Exp. Ther., 309, 56 (2004)
- Kathuria, Nat. Med., 9, 76 (2003)
- Rutkowska, Pharmacol. Rep., 58, 200 (2006)
- Sarker, FEBS Lett., 472, 39 (2000)
- Mimeault, Prostate, 56, 1 (2003)
- Melck, FEBS Lett., 463, 235 (1999)
- Fowler, Biochem. Pharmacol., 66, 757 (2003)
- Patsos, Gut, 54, 1741 (2005)
- Laezza, FEBS Lett., 580, 6076 (2006)
- Helliwell, J. Clin. Endocrinol. Metab., 89, 5168 (2004)
- Habayeb, J. Clin. Endocrinol. Metab., 89, 5482 (2004)
- Habayeb, Life Sci., 70, 1963 (2002)
- Castellano, Behav. Pharmacol., 8, 707 (1997)
- Mallet, Psychopharmacology, 140, 11 (1998)
- Barros, Brain Res., 1016, 66 (2004)
- Varvel, J. Pharmacol. Exp. Ther., 317, 251 (2006)
- Kirkham, Behav. Pharmacol., 16, 297 (2005)
- Mechoulam R, Berry E M, Avraham Y, Di Marzo V, Fride E, Endocannabinoids, feeding and suckling – from our perspective, 10.1038/sj.ijo.0803274
- Matias I, Bisogno T, Di Marzo V, Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake, 10.1038/sj.ijo.0803271
- Mackie, Mol. Pharmacol., 44, 498 (1993)
- Vogel, J. Neurochem., 61, 352 (1993)
- Matias, Prostaglandins Leukot. Essent. Fatty Acids, 75, 413 (2006)
- Felder, FEBS Lett., 393, 231 (1996)
- Giuffrida, FEBS Lett., 422, 373 (1998)
- Smart, Br. J. Pharmacol., 129, 227 (2000)
- Al-Hayani, Neuropharmacology, 41, 1000 (2001)
- Caterina, Nature, 398, 436 (1999)
- Gunthorpe, Trends Pharmacol. Sci., 23, 183 (2002)
- Garcia, Naunyn Schmiedebergs Arch. Pharmacol., 368, 270 (2003)
- Wang, Hypertension, 46, 986 (2005)
- Mechoulam, Biochem. Pharmacol., 50, 83 (1995)
- Sugiura, Biochem. Biophys. Res. Commun., 215, 89 (1995)
- Stella, Nature, 388, 773 (1997)
- Savinainen, Br. J. Pharmacol., 134, 664 (2001)
- Gonsiorek, Mol. Pharmacol., 57, 1045 (2000)
- Sugiura, J. Biol. Chem., 275, 605 (2000)
- Panikashvili, Nature, 413, 527 (2001)
- Panikashvili, Neurobiol. Dis., 22, 257 (2006)
- Lepicier, Br. J. Pharmacol., 139, 805 (2003)
- Wagner, J. Cardiovasc. Pharmacol., 47, 650 (2006)
- Melck, Endocrinology, 141, 118 (2000)
- Nithipatikom, Cancer Res., 64, 8826 (2004)
- Porter, J. Pharmacol. Exp. Ther., 301, 1020 (2002)
- Bisogno, Biochem. J., 351, 817 (2000)
- Huang, Proc. Natl. Acad. Sci. U.S.A., 99, 8400 (2002)
- Toth, Life Sci., 73, 487 (2003)
- O'Sullivan, Br. J. Pharmacol., 141, 803 (2004)
- O'Sullivan, Eur. J. Pharmacol., 507, 211 (2005)
- Huang, J. Neurophysiol., 95, 1207 (2006)
- Sancho R., de la Vega L., Macho A., Appendino G., Di Marzo V., Munoz E., Mechanisms of HIV-1 Inhibition by the Lipid Mediator N-Arachidonoyldopamine, 10.4049/jimmunol.175.6.3990
- Saghatelian, Biochemistry, 43, 14332 (2004)
- Saghatelian, Biochemistry, 45, 9007 (2006)
- Bachur, J. Biol. Chem., 240, 1019 (1965)
- Kondo, Arch. Biochem. Biophys., 354, 303 (1998)
- Calignano, Nature, 394, 277 (1998)
- Baker, FASEB J., 15, 300 (2001)
- Epps, Biochem. Biophys. Res. Commun., 90, 628 (1979)
- Lambert, Epilepsia, 42, 321 (2001)
- Petrocellis, Fundam. Clin. Pharmacol., 16, 297 (2002)
- Conti, Br. J. Pharmacol., 135, 181 (2002)
- Lambert Didier, Vandevoorde Severine, Jonsson Kent-Olov, Fowler Christopher, The Palmitoylethanolamide Family: A New Class of Anti-Inflammatory Agents ?, 10.2174/0929867023370707
- LoVerme, Mol. Pharmacol., 67, 15 (2005)
- LoVerme, Life Sci., 77, 1685 (2005)
- Tan, Am. Assoc. Pharm. Sci. J., 8 (2006)
- Cravatt, Nature, 384, 83 (1996)
- Giang, Proc. Natl. Acad. Sci. U.S.A., 94, 2238 (1997)
- Bracey, Science, 298, 1793 (2002)
- Dinh, Proc. Natl. Acad. Sci. U.S.A., 99, 10819 (2002)
- Ueda, J. Biol. Chem., 276, 35552 (2001)
- Tsuboi, Biochem. J., 379, 99 (2004)
- Tsuboi, J. Biol. Chem., 280, 11082 (2005)
- Fowler, Biochem. Pharmacol., 69, 1241 (2005)
- Kozak, Curr. Pharm. Des., 10, 659 (2004)
- Stelt, Eur. J. Biochem., 267, 2000 (2000)
- Kozak, J. Biol. Chem., 277, 23278 (2002)
- Deutsch, Biochem. Pharmacol., 46, 791 (1993)
- Desarnaud, J. Biol. Chem., 270, 6030 (1995)
- Ueda, J. Biol. Chem., 270, 23823 (1995)
- Goparaju, Biochem. Pharmacol., 57, 417 (1999)
- Ueda, Prostaglandins Other Lipid Mediat., 61, 19 (2000)
- Ueda, Chem. Phys. Lipids, 108, 107 (2000)
- Patricelli, J. Biol. Chem., 2 (2000)
- McKinney, J. Biol. Chem., 278, 37393 (2003)
- Mor, J. Med. Chem., 47, 4998 (2004)
- Basso, J. Mass Spectrom., 39, 1450 (2004)
- Alexander, Chem. Biol., 12, 1179 (2005)
- Pertwee, Am. Assoc. Pharm. Sci. J., 7 (2005)
- Fowler, Brain Res. Rev., 41, 26 (2003)
- Fowler, Pharmacol. Biochem. Behav., 81, 248 (2005)
- Lambert, J. Med. Chem., 48, 5059 (2005)
- Jonsson, Basic Clin. Pharmacol. Toxicol., 98, 124 (2006)
- Park, Placenta, 24, 473 (2003)
- Erratum, Placenta, 24, 990 (2003)
- Katayama Kazuhisa, Ueda Natsuo, Kurahashi Yuko, Suzuki Hiroshi, Yamamoto Shozo, Kato Itsuo, Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine, 10.1016/s0005-2760(97)00078-7
- Bisogno, Arch. Biochem. Biophys., 370, 300 (1999)
- Yazulla, J. Comp. Neurol., 415, 80 (1999)
- Matsuda, Exp. Eye Res., 64, 707 (1997)
- Glaser, Vis. Neurosci., 22, 693 (2005)
- Hillard Cecilia J., Wilkison Douglas M., Edgemond William S., Campbell William B., Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain, 10.1016/0005-2760(95)00087-s
- Paria, Mol. Reprod. Dev., 45, 183 (1996)
- Paria, Biol. Reprod., 60, 1151 (1999)
- Wang, J. Clin. Invest., 116, 2122 (2006)
- Maurelli, FEBS Lett., 377, 82 (1995)
- Bisogno, J. Biol. Chem., 272, 3315 (1997)
- Jacobsson, Br. J. Pharmacol., 132, 1743 (2001)
- Matias, Eur. J. Biochem., 269, 3771 (2002)
- Aguado, J. Neurosci., 26, 1551 (2006)
- Siegmund, J. Biol. Chem., 281, 10431 (2006)
- Omeir, Biochem. Biophys. Res. Commun., 264, 316 (1999)
- Schmid, J. Biol. Chem., 260, 14145 (1985)
- Egertová, Neuroscience, 119, 481 (2003)
- Patricelli, Biochemistry, 38, 14125 (1999)
- McKinney, Biochemistry, 45, 9016 (2006)
- Cravatt, Proc. Natl. Acad. Sci. U.S.A., 98, 9371 (2001)
- Lichtman, Pain, 109, 319 (2004)
- Clement, J. Neurosci., 23, 3916 (2003)
- Pacher, Am. J. Physiol. Heart Circ. Physiol., 289 (2005)
- Basavarajappa, Neuropharmacology, 50, 834 (2006)
- Huitron-Resendiz, Sleep, 27, 857 (2004)
- Mulder, Biochemistry, 45, 11267 (2006)
- Cupini, Cephalalgia, 26, 277 (2006)
- Bluher, Diabetes, 55, 3053 (2006)
- Steffens, Neurosci. Lett., 385, 13 (2005)
- Wei, J. Biol. Chem., 281, 36569 (2006)
- Tornqvist, J. Biol. Chem., 251, 813 (1976)
- Karlsson, J. Biol. Chem., 272, 27218 (1997)
- Lichtman, J. Pharmacol. Exp. Ther., 302, 73 (2002)
- Karlsson, Gene, 272, 11 (2001)
- Vandevoorde, Curr. Pharm. Des., 11, 2647 (2005)
- Gulyas, Eur. J. Neurosci., 20, 441 (2004)
- Saario, Biochem. Pharmacol., 67, 1381 (2004)
- Vandevoorde, Biochem. Biophys. Res. Commun., 337, 104 (2005)
- Saario, Chem. Biol., 12, 649 (2005)
- Saario, Chem. Biol., 13, 811 (2006)
- Vandevoorde, Br. J. Pharmacol., 150, 186 (2007)
- N. Stella, 16th Annual Symposium on the Cannabinoids, Burlington, Vermont, International Cannabinoid Research Society, 2006, p. 20.
- Ueda, FEBS Lett., 454, 267 (1999)
- Sun Yong-Xin, Tsuboi Kazuhito, Zhao Li-Ying, Okamoto Yasuo, Lambert Didier M., Ueda Natsuo, Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages, 10.1016/j.bbalip.2005.08.010
- O'Neill, FEBS Lett., 330, 156 (1993)
- Hinz, J. Pharmacol. Exp. Ther., 300, 367 (2002)
- Nogawa, J. Neurosci., 17, 2746 (1997)
- Resnick, J. Neurotrauma, 15, 1005 (1998)
- Yasojima K., Tourtellotte W. W., McGeer E. G., McGeer P. L., Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy, 10.1212/wnl.57.6.952
- Cernak, Clin. Exp. Pharmacol. Physiol., 28, 922 (2001)
- Minghetti L., Cardone F., Greco A., Puopolo M., Levi G., Green A. J.E., Knight R., Pocchiari M., Increased CSF levels of prostaglandin E2 in variant Creutzfeldt-Jakob disease, 10.1212/wnl.58.1.127
- Bazan, Prostaglandins Other Lipid Mediat., 68–69, 197 (2002)
- Teismann, Ann. N.Y. Acad. Sci., 991, 272 (2003)
- Prescott, Biochim. Biophys. Acta, 1470 (2000)
- Mizuno, Gastroenterology, 112, 387 (1997)
- Fu, Gastroenterology, 116, 1319 (1999)
- DeWitt, Proc. Natl. Acad. Sci. U.S.A., 85, 1412 (1988)
- Yokoyama, Biochem. Biophys. Res. Commun., 165, 888 (1989)
- Järving, J. Biol. Chem., 279, 13624 (2004)
- Picot, Nature, 367, 243 (1994)
- Luong, Nat. Struct. Biol., 3, 927 (1996)
- Kurumbail, Nature, 384, 644 (1996)
- Erratum, Nature, 385, 555 (1997)
- Bayly, Bioorg. Med. Chem. Lett., 9, 307 (1999)
- Simmons, Pharmacol. Rev., 56, 387 (2004)
- Snipes, J. Pharmacol. Exp. Ther., 313, 668 (2005)
- Kis, J. Pharmacol. Exp. Ther., 315, 1 (2005)
- Smith, Prostaglandins Other Lipid Mediat., 68–69, 115 (2002)
- Lands W.E.M., Samuelsson B., Phospholipid precursors of prostaglandins, 10.1016/0005-2760(68)90168-9
- Vonkeman H., Van Dorp D.A., The action of prostaglandin synthetase on 2-arachidonyl-lecithin, 10.1016/0005-2760(68)90169-0
- Yu, J. Biol. Chem., 272, 21181 (1997)
- Kozak, J. Biol. Chem., 275, 33744 (2000)
- Kozak, J. Biol. Chem., 277, 44877 (2002)
- Coffey, Proc. Natl. Acad. Sci. U.S.A., 94, 657 (1997)
- Weber, J. Lipid Res., 45, 757 (2004)
- Kozak, Biochemistry, 42, 9041 (2003)
- Kozak, J. Biol. Chem., 276, 30072 (2001)
- Matias, J. Pharmacol. Exp. Ther., 309, 745 (2004)
- Nirodi, Proc. Natl. Acad. Sci. U.S.A., 101, 1840 (2004)
- Sang Nan, Zhang Jian, Chen Chu, PGE2glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons : Novel prostanoids in synaptic signalling, 10.1113/jphysiol.2006.105569
- Rockwell, J. Pharmacol. Exp. Ther., 311, 683 (2004)
- Dinchuk, Nature, 378, 406 (1995)
- Morham, Cell, 83, 473 (1995)
- Langenbach, Cell, 83, 483 (1995)
- Iadecola, J. Cereb. Blood Flow Metab., 21, 1436 (2001)
- Bonner James C., Rice Annette B., Ingram Jennifer L., Moomaw Cindy R., Nyska Abraham, Bradbury Alyce, Sessoms Alisha R., Chulada Patricia C., Morgan Daniel L., Zeldin Darryl C., Langenbach Robert, Susceptibility of Cyclooxygenase-2-Deficient Mice to Pulmonary Fibrogenesis, 10.1016/s0002-9440(10)64202-2
- Houchen, Am. J. Physiol. Grastroinvest. Liver Physiol., 279 (2000)
- Schmassmann, Am. J. Physiol. Grastroinvest. Liver Physiol., 290 (2006)
- Camitta, Circulation, 104, 2453 (2001)
- Chillingworth N. L., Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice, 10.1152/ajpregu.00901.2005
- Carey M. A., Bradbury J. A., Seubert J. M., Langenbach R., Zeldin D. C., Germolec D. R., Contrasting Effects of Cyclooxygenase-1 (COX-1) and COX-2 Deficiency on the Host Response to Influenza A Viral Infection, 10.4049/jimmunol.175.10.6878
- Iadecola, Proc. Natl. Acad. Sci. U.S.A., 98, 1294 (2001)
- Wormser, Toxicol. Appl. Pharmacol., 200, 40 (2004)
- Myers, Arthritis Rheum., 43, 2687 (2000)
- Langenbach, Ann. N.Y. Acad. Sci., 889, 52 (1999)
- Loftin, Prostaglandins Other Lipid Mediat., 68–69, 177 (2002)
- Prigge, Biochimie, 79, 629 (1997)
- Sigal, J. Biol. Chem., 263, 5328 (1988)
- Yoshimoto, Prostaglandins Other Lipid Mediat., 68–69, 245 (2002)
- Boyington, Science, 260, 1482 (1993)
- Glickman, Biochemistry, 35, 12882 (1996)
- Zhang, Proc. Natl. Acad. Sci. U.S.A., 89, 485 (1992)
- Kühn Hartmut, Borngräber Sabine, Mammalian 15-Lipoxygenases, Advances in Experimental Medicine and Biology (1999) ISBN:9780306460449 p.5-28, 10.1007/978-1-4615-4861-4_2
- Brash, J. Biol. Chem., 274, 23679 (1999)
- Catalano, Histol. Histopathol., 20, 969 (2005)
- Mehrabian, Curr. Opin. Lipidol., 14, 447 (2003)
- Jakobsson, Proc. Natl. Acad. Sci. U.S.A., 89, 3521 (1992)
- Zadelhoff, Biochem. Biophys. Res. Commun., 248, 33 (1998)
- Moody, Biochemistry, 40, 861 (2001)
- Goulet, Proc. Natl. Acad. Sci. U.S.A., 91, 12852 (1994)
- Chen, Nature, 372, 179 (1994)
- Chen, J. Neuroimmunol., 120, 94 (2001)
- Bailie, J. Immunol., 157, 5221 (1996)
- Goulet J. L., Griffiths R. C., Ruiz P., Mannon R. B., Flannery P., Platt J. L., Koller B. H., Coffman T. M., Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice, 10.4049/jimmunol.167.11.6631
- Cuzzocrea, J. Leukocyte Biol., 73, 739 (2003)
- Patel, Mol. Pharmacol., 66, 220 (2004)
- Sun, J. Biol. Chem., 271, 24055 (1996)
- Vahsen, Horm. Metab. Res., 38, 391 (2006)
- Bleich, J. Clin. Invest., 103, 1431 (1999)
- Reddy, Hypertension, 41, 1294 (2003)
- Gabel, Am. J. Physiol. Heart Circ. Physiol., 280 (2001)
- Walters, Psychopharmacology, 170, 124 (2003)
- Lichtman, J. Pharmacol. Exp. Ther., 311, 441 (2004)
- Wiley, Life Sci., 80, 24 (2006)
Bibliographic reference | Vandevoorde, Severine ; Lambert, Didier M. The multiple pathways of endocannabinoid metabolism: a zoom out.. In: Chemistry & biodiversity, Vol. 4, no. 8, p. 1858-81 (2007) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/29439 |